Cardlytics, Inc. (NASDAQ:CDLX) Insider Nicholas Hollmeyer Lynton Sells 12,460 Shares

Cardlytics, Inc. (NASDAQ:CDLXGet Free Report) insider Nicholas Hollmeyer Lynton sold 12,460 shares of Cardlytics stock in a transaction on Tuesday, April 2nd. The shares were sold at an average price of $13.69, for a total transaction of $170,577.40. Following the completion of the sale, the insider now directly owns 71,355 shares of the company’s stock, valued at approximately $976,849.95. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.

Nicholas Hollmeyer Lynton also recently made the following trade(s):

  • On Wednesday, January 3rd, Nicholas Hollmeyer Lynton sold 15,620 shares of Cardlytics stock. The shares were sold at an average price of $7.77, for a total transaction of $121,367.40.

Cardlytics Price Performance

CDLX opened at $13.65 on Wednesday. The company has a debt-to-equity ratio of 1.91, a current ratio of 1.31 and a quick ratio of 1.31. The company has a market capitalization of $602.10 million, a price-to-earnings ratio of -3.95 and a beta of 1.44. The firm’s fifty day moving average price is $9.19 and its two-hundred day moving average price is $9.80. Cardlytics, Inc. has a 1 year low of $3.26 and a 1 year high of $20.52.

Institutional Investors Weigh In On Cardlytics

A number of hedge funds have recently made changes to their positions in the business. Rhumbline Advisers raised its stake in shares of Cardlytics by 2.6% during the 1st quarter. Rhumbline Advisers now owns 34,150 shares of the company’s stock worth $1,878,000 after purchasing an additional 856 shares during the period. FMR LLC increased its position in shares of Cardlytics by 238.4% during the second quarter. FMR LLC now owns 1,428 shares of the company’s stock valued at $32,000 after buying an additional 1,006 shares during the period. Price T Rowe Associates Inc. MD increased its position in shares of Cardlytics by 7.2% during the second quarter. Price T Rowe Associates Inc. MD now owns 17,580 shares of the company’s stock valued at $392,000 after buying an additional 1,184 shares during the period. American International Group Inc. increased its position in shares of Cardlytics by 7.8% during the fourth quarter. American International Group Inc. now owns 18,168 shares of the company’s stock valued at $167,000 after buying an additional 1,307 shares during the period. Finally, Tower Research Capital LLC TRC increased its position in shares of Cardlytics by 186.5% during the third quarter. Tower Research Capital LLC TRC now owns 2,137 shares of the company’s stock valued at $35,000 after buying an additional 1,391 shares during the period. 68.10% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on CDLX shares. Craig Hallum raised shares of Cardlytics from a “hold” rating to a “buy” rating and lifted their price target for the company from $10.00 to $18.00 in a research report on Friday, March 15th. Needham & Company LLC lifted their price target on shares of Cardlytics from $12.00 to $15.00 and gave the company a “buy” rating in a research report on Friday, March 15th. Finally, Lake Street Capital lifted their price target on shares of Cardlytics from $13.00 to $18.00 and gave the company a “buy” rating in a research report on Friday, March 15th. One research analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $13.20.

Check Out Our Latest Stock Analysis on Cardlytics

About Cardlytics

(Get Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Read More

Insider Buying and Selling by Quarter for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.